COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03663686
Recruitment Status : Completed
First Posted : September 10, 2018
Last Update Posted : July 27, 2020
Information provided by (Responsible Party):
Sunshine Lake Pharma Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 30, 2019
Actual Study Completion Date : January 30, 2019